Complement 3 Glomerulopathy Market Outlook 2025-2035: The 7 major complement 3 glomerulopathy market reached a value of USD 9.3 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach ...
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
The sodium glucose co-transporter 2 (SGLT2) functions in the proximal tubule to reabsorb the bulk of filtered glucose. SGLT2 inhibitors have been developed to promote renal glucose excretion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback